Currently browsing category

Research

A new publication from Celon Pharma S.A. laboratories!

Our new publication on experimental oncology has just appeared! The article entitled “Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma.” by Daria Zdzalik and co-workers was published in Journal of Cancer Research and Clinical Oncology and is freely available via …

Results of Celon’s anti-Alzheimer’s drug research on AD/PD 2013

Celon Pharma S.A. will present the results of one of its R&D projects focused on development of novel drugs for Alzheimer’s disease on The 11th International Conference on Alzheimer’s & Parkinson’s Diseases, Florence, Italy. Poster entitled: “Discovery of Novel GSK3beta Inhibitor Lead Structure Using Sequential Virtual Screening” will be displayed …

We are at the EACR in Barcelona

You can meet us at the The European Association for Cancer Research conference in Barcelona (7-10 July), where we present the results of our studies: NPM-ALK I1171T mutation confers resistance to crizotinib in anaplastic large cell lymphoma. Differential gene transcription response to the treatment with JAK2 inhibitors – Ruxolitinib, SAR302503 …